Zevra Therapeutics Inc Sustainability Reports
Zevra Therapeutics, Inc. is a commercial-stage biopharmaceutical company focused on developing and commercializing therapies for rare diseases. The company offers treatments for conditions such as Niemann-Pick disease type C and urea cycle disorders.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 254900CU6T74V18Y1W18
FIGI: BBG0026ZG1G4
2 reports from 2022 to 2023